Background illustration for clinical trials search

Leukemia Clinical Trials

Browse 1,316 Leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families

for
Leukemia, Non Hodgkin Lymphoma
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 0 - 22

Code: NCT05425992

Recruiting

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

for
Leukemia, Acute Lymphoblastic Leukemia
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 1 - 25

Code: NCT06408194

Phase1, Recruiting

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

for
Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 1+

Code: NCT03630991

Phase1, Recruiting

Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

for
Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT00412594

Phase2, Recruiting

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

for
Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06235801

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

for
Acute Myeloid Leukemia, Acute Lymphoid Leukemia,
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 0 - 50

Code: NCT05322850

Phase1, Phase2, Recruiting

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

for
Recurrent Acute Myeloid Leukemia,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07025564

Phase1, Recruiting

Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03661307

Phase1, Phase2, Recruiting

Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Location: Columbus OH
Sponsor: Seema Bhat

Sex: All

Age: 18+

Code: NCT06757647

Phase2, Recruiting

Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia

for
Survivor of Childhood Cancer, Insomnia,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 20 - 50

Code: NCT07191119

Recruiting

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

for
Stem Cell Transplantation, Myelodysplastic Syndromes,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT07469592

Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

for
Chronic Lymphocytic Leukemia, CLL, Mantle Cell Lymphoma, MCL
Location: Boston MA, Tampa FL, Fort Wayne IN, St Louis MO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06697184

Phase1, Phase2, Recruiting

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

for
Plasma Cell Leukemia
Location: Buffalo NY, Salt Lake City UT
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT07605416

Phase2, Recruiting

Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

for
Chronic Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07269470

Phase2, Recruiting

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Buffalo NY, Pontiac MI, Livonia MI, Canton MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 60+

Code: NCT07437950

Phase2, Recruiting

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

for
Acute Myeloid Leukemia, Adult
Location: Baltimore MD, Chapel Hill NC, Pittsburgh PA,
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland

Sex: All

Age: 18+

Code: NCT06652438

Phase3, Recruiting

Addressing Cancer Care Equity With Social Determinants of Health Screening and Early Intervention

for
Leukemia, Acute
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07671209

Recruiting

Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05672251

Phase2, Recruiting

A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
Recurrent Acute Myeloid Leukemia,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06763341

Phase1, Recruiting

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

for
Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML),
Location: Pittsburgh PA
Sponsor: Sawa Ito, MD

Sex: All

Age: 18+

Code: NCT07565220

Phase1, Recruiting

What are clinical trials for leukemia?

Clinical trials for leukemia are research studies designed to evaluate new treatments, therapies, or diagnostic methods for different types of leukemia, a group of cancers that affect the blood and bone marrow. These trials aim to discover more effective ways to treat leukemia, manage its symptoms, and improve patient outcomes. They may involve testing new drugs, combinations of existing treatments, targeted therapies, immunotherapies, or novel approaches like gene therapy.

Why are leukemia clinical trials important?

Leukemia clinical trials are crucial because they drive advancements in treatment by testing new therapies, improving existing ones, and exploring novel approaches to manage and potentially cure the disease. These trials provide essential data on the safety and effectiveness of new treatments, which can lead to better outcomes and fewer side effects compared to current options.

Types of clinical trials for leukemia

Why participate in a leukemia clinical trial

Who can participate in a clinical trial for leukemia?

How to enroll in a leukemia clinical trial